Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026)

Enovis' (ENOV) quarterly Depreciation & Amortization (CF) came in at $73.4 million in Q2 2026, up 2.69% year-on-year from $71.4 million in Q2 2025, and down 4.75% on a QoQ basis from $77.0 million in Q4 2025.

Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

Enovis (ENOV) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $73.4 million in Q2 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 2.69% year-over-year to $73.4 million in Q2 2026; TTM through Apr 2026 was $296.3 million, a 4.76% increase from a year earlier, with the FY2025 full-year figure at $294.4 million, up 3.36% from the prior year.
  • Depreciation & Amortization (CF) for Q2 2026 stood at $73.4 million, down from $77.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for ENOV reached as high as $97.4 million in Q2 2023 and fell as low as $7.6 million in Q1 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $64.1 million across 5 years, with a median of $71.2 million in 2024.
  • Across the five-year window, Depreciation & Amortization (CF) slumped 88.48% in 2023 and soared 865.08% in 2024, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $52.3 million in 2022, then rose by 8.34% to $56.6 million in 2023, then soared by 31.42% to $74.4 million in 2024, then increased by 3.51% to $77.0 million in 2025, then dropped by 4.75% to $73.4 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $73.4 million in Q2 2026, $77.0 million in Q4 2025, and $74.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Enovis 1.50 Bn 1.47 Bn 365.49 Mn 73.36 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 73.36 Mn
Apr 3, 2026 73.36 Mn
Dec 31, 2025 77.01 Mn
Dec 31, 2025 77.01 Mn
Oct 3, 2025 74.38 Mn
Oct 3, 2025 74.38 Mn
Jul 4, 2025 71.55 Mn
Jul 4, 2025 71.55 Mn
Apr 4, 2025 71.44 Mn
Apr 4, 2025 71.44 Mn
Dec 31, 2024 74.40 Mn
Dec 31, 2024 74.40 Mn
Sep 27, 2024 71.23 Mn
Sep 27, 2024 71.23 Mn
Jun 28, 2024 65.76 Mn
Jun 28, 2024 65.76 Mn
Mar 29, 2024 73.40 Mn
Mar 29, 2024 73.40 Mn
Dec 31, 2023 56.62 Mn
Dec 31, 2023 56.62 Mn